The presence of interleukin-2 (IL-2) and soluble IL-2 receptors (sIL-2R) in the serum and cerebrospinal fluid (CSF) of patients suffering from multiple sclerosis (MS) has been extensively investigated. These studies, however, have produced conflicting results. The only significant finding concerns the frequent detection of increased sIL-2R levels in the serum in patients with relapsing-remitting MS (RRMS), especially after a short interval of time from the last relapse. Whether this finding can be used for clinical purposes requires further investigation. A standardization of the ELISA methods used to detect cytokines in biological fluids is urgently needed. Increased serum and/or CSF levels of IL-2 and sIL-2R strongly confirm a CD4+Th1 activation.
Tavolato B , Gallo P. (1994) Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system. In: S Salvati (Ed), A multi-disciplinary approach to myelin diseases II, Plenum Press, New York , pp 167-175.
2.
Gallo P , Tavolato B. (1996) Cytokines in multiple sclerosis cerebrospinal fluid and serum. In: EJ Thompson , M Trojano , P Livrea (Eds), Cerebrospinal fluid analysis in multiple sclerosis, Springer-Verlag, Milano , pp 93-104.
3.
Voskul RR , Martin R , Bergman Cet al. (1993) T helper 1 (Th1) functional phenotype of human myelin basic protein specific T lymphocytes . Autoimmunity15: 137-142 .
4.
Correale J , McMillan M , McCarthy Ket al. (1995) Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis . Neurology45: 1370-1378 .
5.
Hofman FM , van Hanwehr RI , Dinarello CAet al. (1986) Immunoregulatory molecules and IL-2 receptors identi-fied in multiple sclerosis brain . J Immunol136: 3239-3245 .
6.
Peter JB , Boctor FN , Tourtellotte WW. (1991) Serum and CSF levels of IL-2, sIL-2R, TNFa and IL-1b in chronic progressive multiple sclerosis: expected lack of clinical utility . Neurology41: 121-123 .
7.
Weller M , Stevens A , Sommer Net al. (1991) Comparative analysis of cytokine pattern in immunological, infectious, and oncological neurological diseases . J Neurol Sci104: 215-221 .
8.
Gallo P , Piccinno MG , Pagni S , Tavolato B. (1988) Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients . Ann Neurol24: 795-797 .
9.
Adachi K , Kumamoto T , Araki S. (1989) Interleukin-2 receptor levels indicating relapse in multiple sclerosis (Letter) . Lanceti: 559-560 .
10.
Gallo P , Piccinno MG , Pagni Set al. (1989) Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and IFNg in serum and cerebrospinal fluid . J Neurol Sci92: 9-15 .
11.
Adachi K , Kumamoto T , Araki S. (1990) Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis . Ann Neurol28: 687-691 .
12.
Trotter JL , van der Veen RC , Clifford DB. (1990) Serial studies of interleukin-2 in chronic progressive multiple sclerosis: occurrence of `bursts' and effect of cyclosporine . J Neuroimmunol28: 9-14 .
13.
Gallo P , Piccinno MG , Tavolato B , Sidèn Å. (1991) A longitudinal study on IL-2, sIL-2R, IL-4 and IFNg in mutliple sclerosis CSF and serum . J Neurol Sci101: 227-232 .
14.
Hartung H-P , Reiners K , Schmidt Bet al. (1991) Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis . Ann Neurol30: 48-53 .
15.
Trotter JL , Collins KG , van der Veen RC. (1991) Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-a levels . J Neuroimmunol33: 29-36 .
16.
Sharief MK , Hentges R , Thompson EJ. (1991) The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis . J Neuroimmunol32: 43-51 .
17.
Ott M , Demisch L , Engelhardt W , Fisher P-A. (1993) Interleukin-2, soluble interleukin-2 receptor, neopterin, L-tryptophan, and b2 microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis . JNeurol241: 108-114 .
18.
Sharief MK , Thompson EJ. (1993) Correlation of inter-leukin-2 and soluble interleukin-2 receptors with clinical activity of multiple sclerosis . J Neurol Neurosur Psychiatry56: 169-174 .
19.
Greenberg SJ , Marcon L , Hurwitz BJet al. (1988) Elevated levels of soluble interleukin 2 receptors in multiple sclerosis (Letter) . N Engl J Med319: 1206-1206 .
20.
Capra R , Mattioli F , Marciano Net al. (1990) Significantly higher levels of soluble interleukin 2 in patients with relapsing-remitting multiple sclerosis compared to healthy subjects (Letter) . Arch Neurol47: 254-254 .
21.
Hartung H-P , Hughes RAC , Taylor WAet al. (1990) T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors . Neurology40: 215-218 .
22.
Kittur SD , Kittur DS , Soncrant TTet al. (1990) Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders . Ann Neurol28: 169-173 .
23.
Bansil S , Troiano R , Cook SD , Rohowsky-Kochan C. (1991) Serum soluble interleukin-2 receptor levels in chronic progressive, stable, and steroid treated multiple sclerosis . Acta Neurol Scand84: 282-285 .
24.
Fesenmeier JT , Whitaker JN , Herman PK , Walker DP. (1991) Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis . J Neuroimmunol34: 77-80 .
25.
Chalon MP , Sindic CJM , Laterre EC. (1993) Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal . Acta Neurol Scand87: 77-82 .
26.
Sharief MK , Hentges R , Ciardi M , Thompson EJ. (1993) In vivo relationship of interleukin-2 and soluble interleukin-2 receptor with clinical activity in multiple sclerosis . JNeurol240: 46-50 .
27.
Link J , Söderström M , Olsson Tet al. (1995) Increased TGFb, IL-4 and IFNg in multiple sclerosis . Ann Neurol36: 379-386 .
28.
Rieckmann P , Albrecht B , Kitze Bet al. (1995) Tumor necrosis factor-a messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity . Ann Neurol37: 82-88 .
29.
Jung T , Schauer U , Heusser Cet al. (1993) Detection of intracellular cytokines by flow cytometry . J Immunol Meth159: 197-207 .
30.
Openshaw P , Murphy EE , Hosken NAet al. (1995) Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and 2 population . J Exp Med182: 1357-1367 .
